October is Breast Cancer Awareness Month, making it a timely opportunity for employers to review how 2026 breast cancer screening coverage requirements affect their group health plans.
A process put in place by the federal No Surprises Act (NSA) to resolve payment disputes is costing insurers and health plans billions of dollars, according to one organization’s estimate.
Today’s blog recaps recently issued guidance addressing questions raised in a series of lawsuits against health-contingent wellness programs and the tobacco surcharges used in some group health plans.
Medical stop-loss premiums in 2026 show increase from 13.6% on a $100,000 deductible to 15.9% on a $750,000 deductible, as reported by the 2026 Aegis Risk Medical Stop-Loss Premium Survey.
For employer-sponsored group health plans, the impending change from global bundle to CPT-code billing for maternity care could bring better visibility while raising new questions about costs, administration and the participant experience.
U.S. employers project a median health care cost increase of 10% for 2027, according to Health Care Costs Pulse Survey: 2027 Cost Trend, a new survey from the International Foundation of Employee Benefit Plans.
Newly released International Foundation survey data revealed key trends for glucagon-like peptide-1 (GLP-1) drug coverage for U.S. corporate employers.
Learn about the newly proposed requirements for excepted fertility benefits, the design and cost flexibilities available to employers, and the key uncertainties to be resolved in today’s blog.
